Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploring.
Li Y, Zhan H, Wu J, Yu J, Cao G, Wu X, Guo B, Liu X, Fan Y, Hu J, Li X, Wu H, Wang Y, Chen Y, Xu X, Yu P, Zhang J.
Li Y, et al. Among authors: zhang j.
Eur J Pharm Biopharm. 2023 Jul;188:153-160. doi: 10.1016/j.ejpb.2023.04.023. Epub 2023 May 2.
Eur J Pharm Biopharm. 2023.
PMID: 37142130
Clinical Trial.